Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy
Clin Gastroenterol Hepatol
.
2022 Apr;20(4):962-963.
doi: 10.1016/j.cgh.2021.04.015.
Epub 2021 Apr 20.
Authors
Sheri Volger
1
,
Ellen Scherl
2
Affiliations
1
Janssen Research & Development, LLC, Spring House, Pennsylvania.
2
New York-Presbyterian Weill Cornell Medical Center, New York, New York.
PMID:
33864935
DOI:
10.1016/j.cgh.2021.04.015
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biological Products* / adverse effects
Colitis*
Female
Humans
Inflammatory Bowel Diseases* / drug therapy
Pregnancy
Substances
Biological Products